Potential Medicare Part D Savings on Ophthalmic Generic Drugs

被引：3
|
作者：
Collet, David A. [1 ]
Urban, Matthew B. [1 ]
Amin, Abha [2 ]
机构：
[1] New York Med Coll, Sch Med, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Dept Ophthalmol, Valhalla, NY USA
来源：
JAMA OPHTHALMOLOGY | 2024年 / 142卷 / 07期
关键词：
D O I：
10.1001/jamaophthalmol.2024.1717
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
This economic evaluation assesses potential Medicare Part D savings on ophthalmic generic drugs if discount coupon prices are used.
引用
收藏
页码：678 / 680
页数：3
相关论文
共 50 条
  • [21] COST SAVINGS FROM GENERIC PROTON PUMP INHIBITORS IN MEDICARE PART D FROM 2013-2016
    Read, Andrew J.
    Kurlander, Jacob E.
    Waljee, Akbar K.
    Saini, Sameer D.
    GASTROENTEROLOGY, 2019, 156 (06) : S260 - S260
  • [22] Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan Reexamination
    Patel, Rajul A.
    Walberg, Mark P.
    Mai, Yvonne
    McElroy, Nataliya
    Mallya, Anil
    Kim, Aesun
    Seo, Justin
    Woelfel, Joseph A.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (02) : 84 - 91
  • [23] Variation in Generic Dispensing Rates in Medicare Part D
    Buttorff, Christine
    Xu, Yifan
    Joyce, Geoffrey
    AMERICAN JOURNAL OF MANAGED CARE, 2020, 26 (11): : E355 - +
  • [24] Potential Cost Savings in Medicare Part D Across Gastroenterology: An Assessment of Alternative Drug Sourcing
    Bouvette, Christopher A.
    Bouvette, Max
    Yohannan, Bryce
    Rumman, Amir
    Ali, Ijlal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (04): : 764 - 767
  • [25] Proton pump-inhibitor : No potential for savings by generic drugs
    Pressemitteilung, Nach einer
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2007, 45 (12): : 1352 - 1352
  • [26] Potential Savings From Greater Use of $4 Generic Drugs
    Zhang, Yuting
    Zhou, Lei
    Gellad, Walid F.
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (05) : 468 - 469
  • [27] Cost savings from Medicare Part D plan comparisons
    O'Connell, Mary Beth
    Pelaccio, Karli
    Tabon, Patrick K.
    Rashid, Zenab
    Na, Sharon Y.
    Thomas, Hanadi
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (04) : 1275 - 1279
  • [28] Coverage of New Drugs in Medicare Part D
    Naci, Huseyin
    Kyriopoulos, Ilias
    Feldman, William B.
    Hwang, Thomas J.
    Kesselheim, Aaron S.
    Chandra, Amitabh
    MILBANK QUARTERLY, 2022, 100 (02): : 562 - 588
  • [29] Quality of Generic Ophthalmic Drugs
    Novack, Gary D.
    OCULAR SURFACE, 2013, 11 (01): : 54 - 57
  • [30] PRICE TRAJECTORIES ASSESSMENT FOR INJECTABLE MEDICARE PART B GENERIC DRUGS
    Gordon, N.
    Ben-Aharon, O.
    Goldstein, D. A.
    VALUE IN HEALTH, 2017, 20 (05) : A28 - A28
12345